HF
VIVS

HRT Financial’s VivoSim Labs VIVS Stock Holding History

HRT Financial’s Portfolio VIVS Stock Details VIVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-31,602
Closed -$92K – 4314
2025
Q3 		$92K Buy
+31,602
New +$74.9K ﹤0.01% 2539
2020
Q3 		– Sell
-54
Closed -$7K – 2464
2020
Q2 		$7K Buy
+54
New +$6.58K ﹤0.01% 1485
2015
Q3 		– Sell
-107
Closed -$96K – 202
2015
Q2 		$96K Buy
+107
New +$120K 0.05% 154

Other funds holding VIVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return

HRT Financial's VIVS Position: Q4 2025 in Review

HRT Financial sold out of VivoSim Labs (VIVS) in Q4 2025, closing a stake of 31,602 shares — an estimated $92K sold.

HRT Financial first reported a position in VIVS in Q2 2015 and held it in 3 quarters. The position peaked at $96K in Q2 2015. 27 funds tracked by Wall St. Rank hold VIVS as of Q4 2025.

  • HRT Financial reported no remaining VivoSim Labs position as of Q4 2025 after selling out during the quarter.
  • HRT Financial sold 31,602 VivoSim Labs shares in Q4 2025, an estimated $92K.
  • HRT Financial first reported a position in VivoSim Labs in Q2 2015 and held it in 3 quarters.
  • HRT Financial's VivoSim Labs position peaked at $96K in Q2 2015.
  • 27 funds tracked by Wall St. Rank held VivoSim Labs as of Q4 2025.

Based on HRT Financial's 13F filing for Q4 2025, filed 12 Feb 2026.